Dr. David Jablons earned his medical degree from Albany Medical College. He completed his general surgery residency at Tufts-New England Medical Center and his cardiothoracic surgery fellowship at New York Hospital at Cornell University.
He currently practices as a thoracic surgeon at the University of California, San Francisco (UCSF), where he also serves as Professor, Chief of Thoracic Surgery, and leader of the Thoracic Oncology Program. His special area of interest is thoracic malignancy, including lung cancer and mesothelioma.
Dr. David Jablons and his team continue to work tirelessly to discover novel therapies that may one day cure asbestos-related cancers like lung cancer and mesothelioma.
Dr. Jablons also serves as director of the UCSF Thoracic Oncology Laboratory. He studies the molecular biology and genomics of thoracic malignancies. His lab’s bank of thoracic tissues is one of the largest thoracic tissue banks in the world. He has earned a grant from the National Institutes of Health for his research on mesothelioma.
Dr. Jablons has collaborated with some of the leading researchers in the field of asbestos-related malignancy, such as Dr. David Sugarbaker. He has contributed 28 articles to the field as an author and co-author. Dr. Jablons and his team continue to work tirelessly to discover novel therapies that may one day cure asbestos-related cancers like lung cancer and mesothelioma.